MAT2A and hepatocellular carcinoma: This switch in MAT gene expression is proposed to facilitate the rapid cell growth and provide a proliferative advantage for cancer [15], and also makes MAT2A/MAT2B an attractive target for chemoprevention and treatment of HCC [16].